QUOTE AND NEWS
TheStreet.com  Jan 30  Comment 
NEW YORK (TheStreet) -- Align Technology  shares are down 8.53% to $53.67 in early market trading on Friday following the release of the medical device manufacturer's fourth-quarter earnings results after the closing bell yesterday. The San...
Benzinga  Jan 30  Comment 
Analysts at JMP Securities downgraded Align Technology Inc. (NASDAQ: ALGN) from Market Outperform to Market Perform and removed the target price of $63.00. Align Technology shares have dropped 1.26% over the past 52 weeks, while the S&P 500...
Benzinga  Jan 30  Comment 
Deckers Outdoor Corp. (NYSE: DECK) shares declined 14.91% to $70.00 in pre-market trading after the company reported downbeat Q3 results and lowered its Q4 earnings forecast. Align Technology Inc. (NASDAQ: ALGN) shares dropped 9.32% to $53.20...
Motley Fool  Jan 29  Comment 
Align Technology's Q4 results and financial outlook disappointed investors. Here's why.
Motley Fool  Jan 27  Comment 
Align Technology investors will be all smiles if the company delivers on these areas.
Market Intelligence Center  Jan 20  Comment 
For a hedged play on Align Technology Inc (ALGN), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Apr. '15 $55.00 covered call for a net debit in the $52.02 area. That is also the break-even stock price for the...
Market Intelligence Center  Jan 12  Comment 
For a hedged play on Align Technology Inc (ALGN) MarketIntelligenceCenter.com’s patented trade-picking algorithms recommend the Apr. '15 $60.00 covered call for a net debit in the $57.08 area. That is also the break-even stock price for the...
Market Intelligence Center  Jan 8  Comment 
A covered call identified by MarketIntelligececenter.com's patented algorithm on Align Technology Inc (ALGN) could yield about 4.23% (15.58% annualized, for comparison purposes only) in 99 days. Pair a long position in the stock with the Apr. '15...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki